Market Tracker

05/29 6:02pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

163.84
Delayed Data
As of May 29
 -2.35 / -1.41%
Today’s Change
150.06
Today|||52-Week Range
203.30
-11.45%
Year-to-Date

Today’s Trading

Previous close166.19
Today’s open165.59
Day’s range162.27 - 166.66
Volume1,724,626
Average volume (3 months)1,795,749
Market cap$33.2B
Dividend yield--
Data as of 4:14pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+0.23%
Earnings growth (next 5 years)+21.56%
Revenue growth (last year)+46.49%
P/E ratio56.1
Price/Sales16.55
Price/Book10.02

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.89+0.70%
MYLMylan NV-0.05-0.07%
PRGOPerrigo Company PLC-3.66-1.89%
ZTSZoetis Inc+0.66+1.34%
Data as of 4:03pm ET, 05/29/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.38
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts